Treatment-Emergent Adverse Events In Lenalidomide-Treated Low/Int-1-Risk Myelodysplastic Syndromes Patients Without Del(5Q) Ineligible For Or Refractory To Erythropoiesis Stimulating Agents

AuthID
 P-00K-Q86
14
Author(s)
Fenaux, P
·
Garcia Manero, G
·
Giagounidis, A
·
Goldberg, S
·
Groepper, S
·
Jonasova, A
·
Mufti, GJ
·
Sanz, GF
·
Vey, N
·
Castaneda, C
·
Zhong, J
·
Beach, C
·
Santini, V
Document Type
Abstract
Year published
2016
Published
in HAEMATOLOGICA, ISSN: 0390-6078
Volume: 101, Pages: 502-502 (1)
Conference
21St Congress of the European-Hematology-Association, Date: JUN 09-12, 2016, Location: Copenhagen, DENMARK, Sponsors: European Hematol Assoc
Indexing
Wos®
Publication Identifiers
Wos: WOS:000379484602004
Source Identifiers
ISSN: 0390-6078
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2026 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service